Atlas Trials

Study of Lenalidomide (Revlimid) in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL) Patients

Clinical trial NCT01036399 · TERMINATED

Trial details

NCT number
NCT01036399
Sponsor
University of Bologna
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Peripheral T-cell Lymphoma
Start date
2008-11-01
Primary completion
2009-08-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.